#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=Alternatively, protein or proteinaceous material may be hydrolyzed enzymatically.
1-1	0-13	Alternatively	_	_	
1-2	13-14	,	_	_	
1-3	15-22	protein	_	_	
1-4	23-25	or	_	_	
1-5	26-39	proteinaceous	_	_	
1-6	40-48	material	_	_	
1-7	49-52	may	_	_	
1-8	53-55	be	_	_	
1-9	56-66	hydrolyzed	_	_	
1-10	67-80	enzymatically	_	_	
1-11	80-81	.	_	_	

#Text=Typically, the relevant protein source is first subjected to a (partial) hydrolysis with one or more suitable endoproteases.
2-1	82-91	Typically	_	_	
2-2	91-92	,	_	_	
2-3	93-96	the	_	_	
2-4	97-105	relevant	_	_	
2-5	106-113	protein	_	_	
2-6	114-120	source	_	_	
2-7	121-123	is	_	_	
2-8	124-129	first	_	_	
2-9	130-139	subjected	_	_	
2-10	140-142	to	_	_	
2-11	143-144	a	_	_	
2-12	145-146	(	_	_	
2-13	146-153	partial	_	_	
2-14	153-154	)	_	_	
2-15	155-165	hydrolysis	_	_	
2-16	166-170	with	_	_	
2-17	171-174	one	_	_	
2-18	175-177	or	_	_	
2-19	178-182	more	_	_	
2-20	183-191	suitable	_	_	
2-21	192-205	endoproteases	_	_	
2-22	205-206	.	_	_	

#Text=Then, the resulting protein fragments can be degraded completely or partially into individual amino acids or dipeptides or tripeptides by the use of exopeptidases.
3-1	207-211	Then	_	_	
3-2	211-212	,	_	_	
3-3	213-216	the	_	_	
3-4	217-226	resulting	_	_	
3-5	227-234	protein	_	_	
3-6	235-244	fragments	_	_	
3-7	245-248	can	_	_	
3-8	249-251	be	_	_	
3-9	252-260	degraded	_	_	
3-10	261-271	completely	_	_	
3-11	272-274	or	_	_	
3-12	275-284	partially	_	_	
3-13	285-289	into	_	_	
3-14	290-300	individual	_	_	
3-15	301-306	amino	_	_	
3-16	307-312	acids	_	_	
3-17	313-315	or	_	_	
3-18	316-326	dipeptides	_	_	
3-19	327-329	or	_	_	
3-20	330-341	tripeptides	_	_	
3-21	342-344	by	_	_	
3-22	345-348	the	_	_	
3-23	349-352	use	_	_	
3-24	353-355	of	_	_	
3-25	356-369	exopeptidases	_	_	
3-26	369-370	.	_	_	

#Text=Alternatively, the endopeptidases and exopeptidases may function simultaneously in an enzyme mixture resulting in a similar complete or partial degradation of the protein or proteinaceous material.
4-1	371-384	Alternatively	_	_	
4-2	384-385	,	_	_	
4-3	386-389	the	_	_	
4-4	390-404	endopeptidases	_	_	
4-5	405-408	and	_	_	
4-6	409-422	exopeptidases	_	_	
4-7	423-426	may	_	_	
4-8	427-435	function	_	_	
4-9	436-450	simultaneously	_	_	
4-10	451-453	in	_	_	
4-11	454-456	an	_	_	
4-12	457-463	enzyme	_	_	
4-13	464-471	mixture	_	_	
4-14	472-481	resulting	_	_	
4-15	482-484	in	_	_	
4-16	485-486	a	_	_	
4-17	487-494	similar	_	_	
4-18	495-503	complete	_	_	
4-19	504-506	or	_	_	
4-20	507-514	partial	_	_	
4-21	515-526	degradation	_	_	
4-22	527-529	of	_	_	
4-23	530-533	the	_	_	
4-24	534-541	protein	_	_	
4-25	542-544	or	_	_	
4-26	545-558	proteinaceous	_	_	
4-27	559-567	material	_	_	
4-28	567-568	.	_	_	

#Text=A fundamental problem in the enzymatic hydrolysis of proteins and proteinaceous material is the formation of a bitter flavor due to the formation of short peptide fragments.
5-1	569-570	A	*[1]	7-5[2_1]	
5-2	571-582	fundamental	*[1]	_	
5-3	583-590	problem	*[1]	_	
5-4	591-593	in	*[1]	_	
5-5	594-597	the	*[1]	_	
5-6	598-607	enzymatic	*[1]	_	
5-7	608-618	hydrolysis	*[1]	_	
5-8	619-621	of	*[1]	_	
5-9	622-630	proteins	*[1]	_	
5-10	631-634	and	*[1]	_	
5-11	635-648	proteinaceous	*[1]	_	
5-12	649-657	material	*[1]	_	
5-13	658-660	is	*[1]	_	
5-14	661-664	the	*[1]	_	
5-15	665-674	formation	*[1]	_	
5-16	675-677	of	*[1]	_	
5-17	678-679	a	*[1]	_	
5-18	680-686	bitter	*[1]	_	
5-19	687-693	flavor	*[1]	_	
5-20	694-697	due	*[1]	_	
5-21	698-700	to	*[1]	_	
5-22	701-704	the	*[1]	_	
5-23	705-714	formation	*[1]	_	
5-24	715-717	of	*[1]	_	
5-25	718-723	short	*[1]	_	
5-26	724-731	peptide	*[1]	_	
5-27	732-741	fragments	*[1]	_	
5-28	741-742	.	*[1]	_	

#Text=The bitter taste is believed to be the result of cleavage of proteins at amino acids with hydrophobic side chains, resulting in the formation of peptides with exposed hydrophobic side chains, which are typically inaccessible in proteins and longer peptides due to their tertiary structure.
6-1	743-746	The	_	_	
6-2	747-753	bitter	_	_	
6-3	754-759	taste	_	_	
6-4	760-762	is	_	_	
6-5	763-771	believed	_	_	
6-6	772-774	to	_	_	
6-7	775-777	be	_	_	
6-8	778-781	the	_	_	
6-9	782-788	result	_	_	
6-10	789-791	of	_	_	
6-11	792-800	cleavage	_	_	
6-12	801-803	of	_	_	
6-13	804-812	proteins	_	_	
6-14	813-815	at	_	_	
6-15	816-821	amino	_	_	
6-16	822-827	acids	_	_	
6-17	828-832	with	_	_	
6-18	833-844	hydrophobic	_	_	
6-19	845-849	side	_	_	
6-20	850-856	chains	_	_	
6-21	856-857	,	_	_	
6-22	858-867	resulting	_	_	
6-23	868-870	in	_	_	
6-24	871-874	the	_	_	
6-25	875-884	formation	_	_	
6-26	885-887	of	_	_	
6-27	888-896	peptides	_	_	
6-28	897-901	with	_	_	
6-29	902-909	exposed	_	_	
6-30	910-921	hydrophobic	_	_	
6-31	922-926	side	_	_	
6-32	927-933	chains	_	_	
6-33	933-934	,	_	_	
6-34	935-940	which	_	_	
6-35	941-944	are	_	_	
6-36	945-954	typically	_	_	
6-37	955-967	inaccessible	_	_	
6-38	968-970	in	_	_	
6-39	971-979	proteins	_	_	
6-40	980-983	and	_	_	
6-41	984-990	longer	_	_	
6-42	991-999	peptides	_	_	
6-43	1000-1003	due	_	_	
6-44	1004-1006	to	_	_	
6-45	1007-1012	their	_	_	
6-46	1013-1021	tertiary	_	_	
6-47	1022-1031	structure	_	_	
6-48	1031-1032	.	_	_	

#Text=In order to solve this problem, the state of the art proposes to use specific proteases to limit the degree of hydrolysis and obtain preferred terminal side-chains.
7-1	1033-1035	In	_	_	
7-2	1036-1041	order	_	_	
7-3	1042-1044	to	_	_	
7-4	1045-1050	solve	_	_	
7-5	1051-1055	this	*[2]	_	
7-6	1056-1063	problem	*[2]	_	
7-7	1063-1064	,	_	_	
7-8	1065-1068	the	_	_	
7-9	1069-1074	state	_	_	
7-10	1075-1077	of	_	_	
7-11	1078-1081	the	_	_	
7-12	1082-1085	art	_	_	
7-13	1086-1094	proposes	_	_	
7-14	1095-1097	to	_	_	
7-15	1098-1101	use	_	_	
7-16	1102-1110	specific	_	_	
7-17	1111-1120	proteases	_	_	
7-18	1121-1123	to	_	_	
7-19	1124-1129	limit	_	_	
7-20	1130-1133	the	_	_	
7-21	1134-1140	degree	_	_	
7-22	1141-1143	of	_	_	
7-23	1144-1154	hydrolysis	_	_	
7-24	1155-1158	and	_	_	
7-25	1159-1165	obtain	_	_	
7-26	1166-1175	preferred	_	_	
7-27	1176-1184	terminal	_	_	
7-28	1185-1196	side-chains	_	_	
7-29	1196-1197	.	_	_	

#Text=For example, U.S.
8-1	1198-1201	For	_	_	
8-2	1202-1209	example	_	_	
8-3	1209-1210	,	_	_	
8-4	1211-1214	U.S	_	_	
8-5	1214-1215	.	_	_	

#Text=Pat.
9-1	1216-1219	Pat	_	_	
9-2	1219-1220	.	_	_	

#Text=No. 5,866,357 describes the use of a Glu/Asp specific protease for the preparation of hydrolysates, optionally with the use of an additional specific protease.
10-1	1221-1223	No	_	_	
10-2	1223-1224	.	_	_	
10-3	1225-1234	5,866,357	_	_	
10-4	1235-1244	describes	_	_	
10-5	1245-1248	the	_	_	
10-6	1249-1252	use	_	_	
10-7	1253-1255	of	_	_	
10-8	1256-1257	a	_	_	
10-9	1258-1261	Glu	_	_	
10-10	1261-1262	/	_	_	
10-11	1262-1265	Asp	_	_	
10-12	1266-1274	specific	_	_	
10-13	1275-1283	protease	_	_	
10-14	1284-1287	for	_	_	
10-15	1288-1291	the	_	_	
10-16	1292-1303	preparation	_	_	
10-17	1304-1306	of	_	_	
10-18	1307-1319	hydrolysates	_	_	
10-19	1319-1320	,	_	_	
10-20	1321-1331	optionally	_	_	
10-21	1332-1336	with	_	_	
10-22	1337-1340	the	_	_	
10-23	1341-1344	use	_	_	
10-24	1345-1347	of	_	_	
10-25	1348-1350	an	_	_	
10-26	1351-1361	additional	_	_	
10-27	1362-1370	specific	_	_	
10-28	1371-1379	protease	_	_	
10-29	1379-1380	.	_	_	

#Text=Furthermore, WO 98/27827, for example, proposes, for the purpose of solving the problem, using a proteolytic enzyme mixture comprising only one exopeptidase, wherein the exopeptidase is produced using rDNA techniques, and may be employed in combination with one or more suitable endopeptidases, such as Fromase.TM.
11-1	1381-1392	Furthermore	_	_	
11-2	1392-1393	,	_	_	
11-3	1394-1396	WO	_	_	
11-4	1397-1399	98	_	_	
11-5	1399-1400	/	_	_	
11-6	1400-1405	27827	_	_	
11-7	1405-1406	,	_	_	
11-8	1407-1410	for	_	_	
11-9	1411-1418	example	_	_	
11-10	1418-1419	,	_	_	
11-11	1420-1428	proposes	_	_	
11-12	1428-1429	,	_	_	
11-13	1430-1433	for	_	_	
11-14	1434-1437	the	_	_	
11-15	1438-1445	purpose	_	_	
11-16	1446-1448	of	_	_	
11-17	1449-1456	solving	_	_	
11-18	1457-1460	the	_	_	
11-19	1461-1468	problem	_	_	
11-20	1468-1469	,	_	_	
11-21	1470-1475	using	_	_	
11-22	1476-1477	a	_	_	
11-23	1478-1489	proteolytic	_	_	
11-24	1490-1496	enzyme	_	_	
11-25	1497-1504	mixture	_	_	
11-26	1505-1515	comprising	_	_	
11-27	1516-1520	only	_	_	
11-28	1521-1524	one	_	_	
11-29	1525-1537	exopeptidase	_	_	
11-30	1537-1538	,	_	_	
11-31	1539-1546	wherein	_	_	
11-32	1547-1550	the	_	_	
11-33	1551-1563	exopeptidase	_	_	
11-34	1564-1566	is	_	_	
11-35	1567-1575	produced	_	_	
11-36	1576-1581	using	_	_	
11-37	1582-1586	rDNA	_	_	
11-38	1587-1597	techniques	_	_	
11-39	1597-1598	,	_	_	
11-40	1599-1602	and	_	_	
11-41	1603-1606	may	_	_	
11-42	1607-1609	be	_	_	
11-43	1610-1618	employed	_	_	
11-44	1619-1621	in	_	_	
11-45	1622-1633	combination	_	_	
11-46	1634-1638	with	_	_	
11-47	1639-1642	one	_	_	
11-48	1643-1645	or	_	_	
11-49	1646-1650	more	_	_	
11-50	1651-1659	suitable	_	_	
11-51	1660-1674	endopeptidases	_	_	
11-52	1674-1675	,	_	_	
11-53	1676-1680	such	_	_	
11-54	1681-1683	as	_	_	
11-55	1684-1694	Fromase.TM	_	_	
11-56	1694-1695	.	_	_	

#Text=(Gist-Brocades, France) and Maxatase.TM.
12-1	1696-1697	(	_	_	
12-2	1697-1710	Gist-Brocades	_	_	
12-3	1710-1711	,	_	_	
12-4	1712-1718	France	_	_	
12-5	1718-1719	)	_	_	
12-6	1720-1723	and	_	_	
12-7	1724-1735	Maxatase.TM	_	_	
12-8	1735-1736	.	_	_	

#Text=(Genencor International, Belgium).
13-1	1737-1738	(	_	_	
13-2	1738-1746	Genencor	_	_	
13-3	1747-1760	International	_	_	
13-4	1760-1761	,	_	_	
13-5	1762-1769	Belgium	_	_	
13-6	1769-1770	)	_	_	
13-7	1770-1771	.	_	_	

#Text=U.S.
14-1	1772-1775	U.S	_	_	
14-2	1775-1776	.	_	_	

#Text=Pat.
15-1	1777-1780	Pat	_	_	
15-2	1780-1781	.	_	_	

#Text=No. 5,532,007 discloses the use of a combination of purified enzymes, a neutral protease producible by means of a Bacillus strain and an alkaline protease producible by means of a Bacillus strain.
16-1	1782-1784	No	_	_	
16-2	1784-1785	.	_	_	
16-3	1786-1795	5,532,007	_	_	
16-4	1796-1805	discloses	_	_	
16-5	1806-1809	the	_	_	
16-6	1810-1813	use	_	_	
16-7	1814-1816	of	_	_	
16-8	1817-1818	a	_	_	
16-9	1819-1830	combination	_	_	
16-10	1831-1833	of	_	_	
16-11	1834-1842	purified	_	_	
16-12	1843-1850	enzymes	_	_	
16-13	1850-1851	,	_	_	
16-14	1852-1853	a	_	_	
16-15	1854-1861	neutral	_	_	
16-16	1862-1870	protease	_	_	
16-17	1871-1881	producible	_	_	
16-18	1882-1884	by	_	_	
16-19	1885-1890	means	_	_	
16-20	1891-1893	of	_	_	
16-21	1894-1895	a	_	_	
16-22	1896-1904	Bacillus	_	_	
16-23	1905-1911	strain	_	_	
16-24	1912-1915	and	_	_	
16-25	1916-1918	an	_	_	
16-26	1919-1927	alkaline	_	_	
16-27	1928-1936	protease	_	_	
16-28	1937-1947	producible	_	_	
16-29	1948-1950	by	_	_	
16-30	1951-1956	means	_	_	
16-31	1957-1959	of	_	_	
16-32	1960-1961	a	_	_	
16-33	1962-1970	Bacillus	_	_	
16-34	1971-1977	strain	_	_	
16-35	1977-1978	.	_	_	

#Text=The reference states that raw meat is preferably treated with proteases exclusively with endo-activities for the purpose of the described invention to obtain meat hydrolysates.
17-1	1979-1982	The	_	_	
17-2	1983-1992	reference	_	_	
17-3	1993-1999	states	_	_	
17-4	2000-2004	that	_	_	
17-5	2005-2008	raw	_	_	
17-6	2009-2013	meat	_	_	
17-7	2014-2016	is	_	_	
17-8	2017-2027	preferably	_	_	
17-9	2028-2035	treated	_	_	
17-10	2036-2040	with	_	_	
17-11	2041-2050	proteases	_	_	
17-12	2051-2062	exclusively	_	_	
17-13	2063-2067	with	_	_	
17-14	2068-2083	endo-activities	_	_	
17-15	2084-2087	for	_	_	
17-16	2088-2091	the	_	_	
17-17	2092-2099	purpose	_	_	
17-18	2100-2102	of	_	_	
17-19	2103-2106	the	_	_	
17-20	2107-2116	described	_	_	
17-21	2117-2126	invention	_	_	
17-22	2127-2129	to	_	_	
17-23	2130-2136	obtain	_	_	
17-24	2137-2141	meat	_	_	
17-25	2142-2154	hydrolysates	_	_	
17-26	2154-2155	.	_	_	

#Text=Methods disclosed in WO 94/25580 employ a proteolytic enzyme preparation derived from the fungus Aspergillus oryzae (Flavorzyme.TM.) comprising a mixture of endopeptidases and exopeptidases.
18-1	2156-2163	Methods	_	_	
18-2	2164-2173	disclosed	_	_	
18-3	2174-2176	in	_	_	
18-4	2177-2179	WO	_	_	
18-5	2180-2182	94	_	_	
18-6	2182-2183	/	_	_	
18-7	2183-2188	25580	_	_	
18-8	2189-2195	employ	_	_	
18-9	2196-2197	a	_	_	
18-10	2198-2209	proteolytic	_	_	
18-11	2210-2216	enzyme	_	_	
18-12	2217-2228	preparation	_	_	
18-13	2229-2236	derived	_	_	
18-14	2237-2241	from	_	_	
18-15	2242-2245	the	_	_	
18-16	2246-2252	fungus	_	_	
18-17	2253-2264	Aspergillus	_	_	
18-18	2265-2271	oryzae	_	_	
18-19	2272-2273	(	_	_	
18-20	2273-2286	Flavorzyme.TM	_	_	
18-21	2286-2287	.	_	_	
18-22	2287-2288	)	_	_	
18-23	2289-2299	comprising	_	_	
18-24	2300-2301	a	_	_	
18-25	2302-2309	mixture	_	_	
18-26	2310-2312	of	_	_	
18-27	2313-2327	endopeptidases	_	_	
18-28	2328-2331	and	_	_	
18-29	2332-2345	exopeptidases	_	_	
18-30	2345-2346	.	_	_	

#Text=Alternatively, EP 0 823 998 A2, proposes the enzymatic hydrolysis of smoked meat as the protein or proteinaceous material for the generation of a protein hydrolysate which does not taste bitter.
19-1	2347-2360	Alternatively	_	_	
19-2	2360-2361	,	_	_	
19-3	2362-2364	EP	_	_	
19-4	2365-2366	0	_	_	
19-5	2367-2370	823	_	_	
19-6	2371-2374	998	_	_	
19-7	2375-2377	A2	_	_	
19-8	2377-2378	,	_	_	
19-9	2379-2387	proposes	_	_	
19-10	2388-2391	the	_	_	
19-11	2392-2401	enzymatic	_	_	
19-12	2402-2412	hydrolysis	_	_	
19-13	2413-2415	of	_	_	
19-14	2416-2422	smoked	_	_	
19-15	2423-2427	meat	_	_	
19-16	2428-2430	as	_	_	
19-17	2431-2434	the	_	_	
19-18	2435-2442	protein	_	_	
19-19	2443-2445	or	_	_	
19-20	2446-2459	proteinaceous	_	_	
19-21	2460-2468	material	_	_	
19-22	2469-2472	for	_	_	
19-23	2473-2476	the	_	_	
19-24	2477-2487	generation	_	_	
19-25	2488-2490	of	_	_	
19-26	2491-2492	a	_	_	
19-27	2493-2500	protein	_	_	
19-28	2501-2512	hydrolysate	_	_	
19-29	2513-2518	which	_	_	
19-30	2519-2523	does	_	_	
19-31	2524-2527	not	_	_	
19-32	2528-2533	taste	_	_	
19-33	2534-2540	bitter	_	_	
19-34	2540-2541	.	_	_	

#Text=In this process it is preferred that only one enzyme, preferably a neutral or an alkaline protease having an endopeptidase effect, for example Pescalase (Gist Brocades), Alcalase (Novo Nordisk) or Promod 31 (Biocatalysts), be employed for the hydrolysis.
20-1	2542-2544	In	_	_	
20-2	2545-2549	this	_	_	
20-3	2550-2557	process	_	_	
20-4	2558-2560	it	_	_	
20-5	2561-2563	is	_	_	
20-6	2564-2573	preferred	_	_	
20-7	2574-2578	that	_	_	
20-8	2579-2583	only	_	_	
20-9	2584-2587	one	_	_	
20-10	2588-2594	enzyme	_	_	
20-11	2594-2595	,	_	_	
20-12	2596-2606	preferably	_	_	
20-13	2607-2608	a	_	_	
20-14	2609-2616	neutral	_	_	
20-15	2617-2619	or	_	_	
20-16	2620-2622	an	_	_	
20-17	2623-2631	alkaline	_	_	
20-18	2632-2640	protease	_	_	
20-19	2641-2647	having	_	_	
20-20	2648-2650	an	_	_	
20-21	2651-2664	endopeptidase	_	_	
20-22	2665-2671	effect	_	_	
20-23	2671-2672	,	_	_	
20-24	2673-2676	for	_	_	
20-25	2677-2684	example	_	_	
20-26	2685-2694	Pescalase	_	_	
20-27	2695-2696	(	_	_	
20-28	2696-2700	Gist	_	_	
20-29	2701-2709	Brocades	_	_	
20-30	2709-2710	)	_	_	
20-31	2710-2711	,	_	_	
20-32	2712-2720	Alcalase	_	_	
20-33	2721-2722	(	_	_	
20-34	2722-2726	Novo	_	_	
20-35	2727-2734	Nordisk	_	_	
20-36	2734-2735	)	_	_	
20-37	2736-2738	or	_	_	
20-38	2739-2745	Promod	_	_	
20-39	2746-2748	31	_	_	
20-40	2749-2750	(	_	_	
20-41	2750-2762	Biocatalysts	_	_	
20-42	2762-2763	)	_	_	
20-43	2763-2764	,	_	_	
20-44	2765-2767	be	_	_	
20-45	2768-2776	employed	_	_	
20-46	2777-2780	for	_	_	
20-47	2781-2784	the	_	_	
20-48	2785-2795	hydrolysis	_	_	
20-49	2795-2796	.	_	_	

#Text=WO 89/10960 proposes the use of complex enzyme mixtures from krill to modificate protein, peptide and/or lipid constituents of biological material in industrial processes.
21-1	2797-2799	WO	_	_	
21-2	2800-2802	89	_	_	
21-3	2802-2803	/	_	_	
21-4	2803-2808	10960	_	_	
21-5	2809-2817	proposes	_	_	
21-6	2818-2821	the	_	_	
21-7	2822-2825	use	_	_	
21-8	2826-2828	of	_	_	
21-9	2829-2836	complex	_	_	
21-10	2837-2843	enzyme	_	_	
21-11	2844-2852	mixtures	_	_	
21-12	2853-2857	from	_	_	
21-13	2858-2863	krill	_	_	
21-14	2864-2866	to	_	_	
21-15	2867-2877	modificate	_	_	
21-16	2878-2885	protein	_	_	
21-17	2885-2886	,	_	_	
21-18	2887-2894	peptide	_	_	
21-19	2895-2898	and	_	_	
21-20	2898-2899	/	_	_	
21-21	2899-2901	or	_	_	
21-22	2902-2907	lipid	_	_	
21-23	2908-2920	constituents	_	_	
21-24	2921-2923	of	_	_	
21-25	2924-2934	biological	_	_	
21-26	2935-2943	material	_	_	
21-27	2944-2946	in	_	_	
21-28	2947-2957	industrial	_	_	
21-29	2958-2967	processes	_	_	
21-30	2967-2968	.	_	_	

#Text=The enzyme compositions disclosed are prepared by incubating macerated whole Antarctic krill (Euphasia superba) at 50.degree.
22-1	2969-2972	The	_	_	
22-2	2973-2979	enzyme	_	_	
22-3	2980-2992	compositions	_	_	
22-4	2993-3002	disclosed	_	_	
22-5	3003-3006	are	_	_	
22-6	3007-3015	prepared	_	_	
22-7	3016-3018	by	_	_	
22-8	3019-3029	incubating	_	_	
22-9	3030-3039	macerated	_	_	
22-10	3040-3045	whole	_	_	
22-11	3046-3055	Antarctic	_	_	
22-12	3056-3061	krill	_	_	
22-13	3062-3063	(	_	_	
22-14	3063-3071	Euphasia	_	_	
22-15	3072-3079	superba	_	_	
22-16	3079-3080	)	_	_	
22-17	3081-3083	at	_	_	
22-18	3084-3086	50	_	_	
22-19	3086-3087	.	_	_	
22-20	3087-3093	degree	_	_	
22-21	3093-3094	.	_	_	

#Text=C. for 20 h.
23-1	3095-3096	C	_	_	
23-2	3096-3097	.	_	_	
23-3	3098-3101	for	_	_	
23-4	3102-3104	20	_	_	
23-5	3105-3106	h	_	_	
23-6	3106-3107	.	_	_	

#Text=Examples of various applications are described, such as hydrolysis of fish and meat.
24-1	3108-3116	Examples	_	_	
24-2	3117-3119	of	_	_	
24-3	3120-3127	various	_	_	
24-4	3128-3140	applications	_	_	
24-5	3141-3144	are	_	_	
24-6	3145-3154	described	_	_	
24-7	3154-3155	,	_	_	
24-8	3156-3160	such	_	_	
24-9	3161-3163	as	_	_	
24-10	3164-3174	hydrolysis	_	_	
24-11	3175-3177	of	_	_	
24-12	3178-3182	fish	_	_	
24-13	3183-3186	and	_	_	
24-14	3187-3191	meat	_	_	
24-15	3191-3192	.	_	_	

#Text=The krill enzyme preparations are said to contain different proteases and lipolytic enzymes, e.g. a considerable amount of phospholipases.
25-1	3193-3196	The	_	_	
25-2	3197-3202	krill	_	_	
25-3	3203-3209	enzyme	_	_	
25-4	3210-3222	preparations	_	_	
25-5	3223-3226	are	_	_	
25-6	3227-3231	said	_	_	
25-7	3232-3234	to	_	_	
25-8	3235-3242	contain	_	_	
25-9	3243-3252	different	_	_	
25-10	3253-3262	proteases	_	_	
25-11	3263-3266	and	_	_	
25-12	3267-3276	lipolytic	_	_	
25-13	3277-3284	enzymes	_	_	
25-14	3284-3285	,	_	_	
25-15	3286-3289	e.g	_	_	
25-16	3289-3290	.	_	_	
25-17	3291-3292	a	_	_	
25-18	3293-3305	considerable	_	_	
25-19	3306-3312	amount	_	_	
25-20	3313-3315	of	_	_	
25-21	3316-3330	phospholipases	_	_	
25-22	3330-3331	.	_	_	

#Text=Such preparations do not seem to have been used on a commercial scale for the production of food-grade hydrolysates.
26-1	3332-3336	Such	_	_	
26-2	3337-3349	preparations	_	_	
26-3	3350-3352	do	_	_	
26-4	3353-3356	not	_	_	
26-5	3357-3361	seem	_	_	
26-6	3362-3364	to	_	_	
26-7	3365-3369	have	_	_	
26-8	3370-3374	been	_	_	
26-9	3375-3379	used	_	_	
26-10	3380-3382	on	_	_	
26-11	3383-3384	a	_	_	
26-12	3385-3395	commercial	_	_	
26-13	3396-3401	scale	_	_	
26-14	3402-3405	for	_	_	
26-15	3406-3409	the	_	_	
26-16	3410-3420	production	_	_	
26-17	3421-3423	of	_	_	
26-18	3424-3434	food-grade	_	_	
26-19	3435-3447	hydrolysates	_	_	
26-20	3447-3448	.	_	_	

#Text=It should be noted that in all of these prior art references, hydrolysates are obtained by enzymatic incubation at 50 65.degree.
27-1	3449-3451	It	_	_	
27-2	3452-3458	should	_	_	
27-3	3459-3461	be	_	_	
27-4	3462-3467	noted	_	_	
27-5	3468-3472	that	_	_	
27-6	3473-3475	in	_	_	
27-7	3476-3479	all	_	_	
27-8	3480-3482	of	_	_	
27-9	3483-3488	these	_	_	
27-10	3489-3494	prior	_	_	
27-11	3495-3498	art	_	_	
27-12	3499-3509	references	_	_	
27-13	3509-3510	,	_	_	
27-14	3511-3523	hydrolysates	_	_	
27-15	3524-3527	are	_	_	
27-16	3528-3536	obtained	_	_	
27-17	3537-3539	by	_	_	
27-18	3540-3549	enzymatic	_	_	
27-19	3550-3560	incubation	_	_	
27-20	3561-3563	at	_	_	
27-21	3564-3566	50	_	_	
27-22	3567-3569	65	_	_	
27-23	3569-3570	.	_	_	
27-24	3570-3576	degree	_	_	
27-25	3576-3577	.	_	_	

#Text=C.
28-1	3578-3579	C	_	_	
28-2	3579-3580	.	_	_	
